➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Merck
Colorcon
Express Scripts
Boehringer Ingelheim

Last Updated: June 19, 2021

DrugPatentWatch Database Preview

LATANOPROST Drug Profile


Email this page to a colleague

« Back to Dashboard

DrugPatentWatch® Litigation and Generic Entry Outlook for Latanoprost

A generic version of LATANOPROST was approved as latanoprost by AMRING PHARMS on March 22nd, 2011.

  Get Started Free

Drug patent expirations by year for LATANOPROST
Drug Prices for LATANOPROST

See drug prices for LATANOPROST

Drug Sales Revenue Trends for LATANOPROST

See drug sales revenues for LATANOPROST

Recent Clinical Trials for LATANOPROST

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Klinički Bolnički Centar ZagrebN/A
University of ZagrebN/A
JeniVision, Inc.Phase 1/Phase 2

See all LATANOPROST clinical trials

Pharmacology for LATANOPROST
Paragraph IV (Patent) Challenges for LATANOPROST
Tradename Dosage Ingredient NDA Submissiondate
XALATAN SOLUTION/DROPS;OPHTHALMIC latanoprost 020597

US Patents and Regulatory Information for LATANOPROST

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn LATANOPROST latanoprost SOLUTION/DROPS;OPHTHALMIC 090887-001 Jul 19, 2011 AT RX No No   Get Started Free   Get Started Free   Get Started Free
Fdc Ltd LATANOPROST latanoprost SOLUTION/DROPS;OPHTHALMIC 202442-001 Apr 22, 2016 AT RX No No   Get Started Free   Get Started Free   Get Started Free
Aurobindo Pharma Ltd LATANOPROST latanoprost SOLUTION/DROPS;OPHTHALMIC 206519-001 Sep 3, 2019 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Sandoz Inc LATANOPROST latanoprost SOLUTION/DROPS;OPHTHALMIC 091449-001 Mar 22, 2011 AT RX No No   Get Started Free   Get Started Free   Get Started Free
Amring Pharms LATANOPROST latanoprost SOLUTION/DROPS;OPHTHALMIC 200925-001 Mar 22, 2011 AT RX No No   Get Started Free   Get Started Free   Get Started Free
Apotex Inc LATANOPROST latanoprost SOLUTION/DROPS;OPHTHALMIC 077697-001 Mar 22, 2011 DISCN No No   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
McKinsey
Moodys
Merck
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.